Efficacy of immune checkpoint inhibitors in renal cell carcinoma venous tumour thrombus shrinkage (UroCCR 128)
These data highlight the potential efficacy of ICIs to shrink the VTT even if they seem to have little impact on the extent of VTT.
Authors
- Fabien Moinard‐Butot (ORCID: https://orcid.org/0000-0002-5630-5220)
- G. Margue (ORCID: https://orcid.org/0000-0001-5311-1597)
- Denis Maillet (ORCID: https://orcid.org/0000-0001-6883-2696)
- Marine Gross‐Goupil (ORCID: https://orcid.org/0000-0002-3176-4076)
- Roberto Luigi Cazzato
- Philippe Boudier
- Jean‐Christophe Bernhard (ORCID: https://orcid.org/0000-0001-8564-1699)
- Pierre Bigot (ORCID: https://orcid.org/0000-0002-5669-9020)
- Jonathan Thouvenin (ORCID: https://orcid.org/0000-0002-1751-4943)
- Nieves Martínez Chanzá (ORCID: https://orcid.org/0000-0002-2340-7415)
- Victor Gaillard (ORCID: https://orcid.org/0000-0003-1586-3995)
- Romain Boissier
- Philippe Barthélémy (ORCID: https://orcid.org/0009-0006-3868-186X)
Institutions
- Université de Bordeaux (FR)
- Institut Jules Bordet (BE)
- Institut de Cancérologie Strasbourg (FR)
- Hôpital de la Conception (FR)
- Hospices Civils de Lyon (FR)
- Bordeaux Population Health (FR)
- Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie (FR)
- Hôpital Civil, Strasbourg (FR)
- Université d'Angers (FR)
Publication Details
- Journal
- World Journal of Urology
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1007/s00345-024-05428-w
- Citations
- 3
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.56